4. Issues of Ethnopharmacology in HIV Management
Suggested Activities
Module 1: HIV Types, Groups, and Clades
- Do you serve a community with significant numbers of patients with demographics at higher risk for HIV-2? If you believe you are likely to serve a patient with HIV-2 in the next year, review the CDC guidelines (insert link).
- If you have patients at-risk for HIV-2 or HIV-1 clades other than B, read Parkin (2004) or Martinez-Cajas (2008) (insert links), and consider how the information presented will affect clinical care management of these patients.
- Select resources from the AETC-NMC library on migrant and immigrant communities that may help you to understand the cultures and needs of your patients at risk for less common HIV variations.
- Review the Agency for Healthcare Research and Quality’s toolkit for modifying practices to increase cultural competence and consider how the recommendations could support your practice in serving patients, especially those at risk for less common variations of HIV/AIDS. http://www.innovations.ahrq.gov/content.aspx?id=3394
Module 2: HIV Tropism: Overview and Practical Considerations
- Identify at least two ways that information presented in the CLAS curriculum could help you to elicit racial and geographic background information from your patients that will inform decisions regarding antiretroviral management.
- Review DHHS guidelines on tropism testing and consider the implications for your practice. Discuss with colleagues and administrators. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf
- Review information about the Trofile assay and discuss with colleagues whether it is appropriate for your practice.
- Consider how you would use information about patient’s culture and ethnicity to determine whether to recommend tropism testing and how it would affect sequencing of antiretroviral agents. How would you explain tropism testing to a patient?
Module 3, Pharmacogenomics’ Role in HIV Management:
- Consider how information about the association between being African American and risks associated with Efavirenz affects the treatment protocol you would recommend for African American patients. What information would you need to determine optimal care? How would you obtain this information? Discuss with colleagues and develop a draft protocol.
- Develop a protocol for monitoring therapeutic parameters to determine optimal atazanavir/ritonavir dosing for Asian patients. Discuss with colleagues.
- Consider how the information about the relationship between race and ribavirin metabolism informs your approach to clinical care management. How would you monitor for indications of a polymorphism affecting drug efficacy? Develop a protocol for monitoring management of HCV and HIV. Discuss with colleagues how to ensure both diseases are managed effectively and with cultural competence.
- Identify how information presented in this module can help you prevent patients from having adverse reactions or virologic failure. Identify at least two recommended culturally competent approaches from Curriculum 1 or resources presented on the AETC-NMC website that could inform efforts to develop optimal HAART for each patient.
Module 4, Ethnopharmacology and the Treatment of HIV Disease:
- Review the AETC-NMC compendium on implications of traditional healing for clinical management of HIV/AIDS (insert link). Select one or more articles relevant to your patient population and implement at least one recommendation.
- Discuss with your clinical team the importance of eliciting information about patients' use of herbal medications. Discuss how to obtain thorough, accurate information. Examples of steps to implement include rephrasing items on clinical history forms and learning local terms for commonly used herbs.
- Consider how coordinating care with your patients' traditional healers could affect clinical care management. How would you ask patients who also see traditional healers about including them on the care team? How would you approach the healer to discuss patient care? If you decide not to discuss a patient's case with his or her traditional healer, how would you address ethnopharmacology issues?
- Ask patients and community members about local traditional healing practices. Visit a traditional herbalist or herb store. Ask which herbs are most commonly prescribed, how, and why. Review the NIH compendium (insert link) information on these herbs' effects. Consider clinical care management implications and how to discuss these implications with patients. Discuss with colleagues.